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IT IS WELL-KNOWN THAT ALZHEIMERdisease adversely affects cognitive,emotional, and behavioral function-ing.1 Less well-known are the del-
eterious effects of Alzheimer disease on
physical conditioning. However, there
are a number of studies linking Alzhei-
mer disease with physical deteriora-
tion. For example, when compared with
age-matched controls, Alzheimer dis-
ease patients show more signs of under-
nutrition,2 higher risk of falls and frac-
tures,3-6 and more rapid decline on
measures of mobility.7,8 Once injured,
Alzheimer disease patients are at greater
risk of subsequent injury than age- and
sex-matched controls.3 Reduced muscle
mass has also been associated with loss
of independence.9 Consequently, im-
proved physical conditioning for pa-
tients with Alzheimer disease may ex-
tend their independent mobility and
enhance their quality of life despite pro-
gression of the disease.
Research is accumulating to sug-
gest that even the oldest adults can im-
prove cardiovascular function and in-
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Context Exercise training for patients with Alzheimer disease combined with teach-
ing caregivers how to manage behavioral problems may help decrease the frailty and
behavioral impairment that are often prevalent in patients with Alzheimer disease.
Objective To determine whether a home-based exercise program combined with
caregiver training in behavioral management techniques would reduce functional de-
pendence and delay institutionalization among patients with Alzheimer disease.
Design, Setting, and Patients Randomized controlled trial of 153 community-
dwelling patients meeting National Institute of Neurological and Communicative Dis-
eases and Stroke/Alzheimer Disease and Related Disorders Association criteria for Alz-
heimer disease, conducted between June 1994 and April 1999.
Interventions Patient-caregiver dyads were randomly assigned to the combined ex-
ercise and caregiver training progam, Reducing Disability in Alzheimer Disease (RDAD),
or to routine medical care (RMC). The RDAD program was conducted in the patients’
home over 3 months.
MainOutcomeMeasures Physical health and function (36-item Short-Form Health
Survey’s [SF-36] physical functioning and physical role functioning subscales and Sick-
ness Impact Profile’s Mobility subscale), and affective status (Hamilton Depression Rat-
ing Scale and Cornell Depression Scale for Depression in Dementia).
Results At 3 months, in comparison with the routine care patients, more patients in
the RDAD group exercised at least 60 min/wk (odds ratio [OR], 2.82; 95% confidence
interval [CI], 1.25-6.39; P=.01) and had fewer days of restricted activity (OR, 3.10;
95% CI, 1.08-8.95; P.001). Patients in the RDAD group also had improved scores
for physical role functioning compared with worse scores for patients in the RMC
group (mean difference, 19.29; 95% CI, 8.75-29.83; P.001). Patients in the RDAD
group had improved Cornell Depression Scale for Depression in Dementia scores while
the patients in the RMC group had worse scores (mean difference, −1.03; 95% CI,
−0.17 to −1.91; P=.02). At 2 years, the RDAD patients continued to have better
physical role functioning scores than the RMC patients (mean difference, 10.89; 95%
CI, 3.62-18.16; P=.003) and showed a trend (19% vs 50%) for less institutionaliza-
tion due to behavioral disturbance. For patients with higher depression scores at base-
line, those in the RDAD group improved significantly more at 3 months on the Hamil-
ton Depression Rating Scale (mean difference, 2.21; 95% CI, 0.22-4.20; P=.04) and
maintained that improvement at 24 months (mean difference, 2.14; 95% CI, 0.14-
4.17; P=.04).
Conclusion Exercise training combined with teaching caregivers behavioral man-
agement techniques improved physical health and depression in patients with Alzhei-
mer disease.
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crease flexibility, balance, and strength
with systematic exercise training.10,11 In
one uncontrolled study of 11 patients
with Alzheimer disease, patients ben-
efited from a hospital-based exercise
program.12 Furthermore, exercise pro-
grams have been shown to improve
function even in frail nursing home resi-
dents.10,11
Exercise can yield additional ben-
efits for elderly dementia patients. In
elderly individuals without dementia,
randomized controlled clinical trials
have demonstrated that exercise suc-
cessfully reduces depression.13-16 Be-
tween 17% and 86% of dementia pa-
tients are depressed.17 Exercise may
provide the added benefit of reducing
their levels of depression.
Because caregivers are responsible for
structuring the patient’s day-to-day ac-
tivities and providing ongoing care,
teaching them effective caregiving strat-
egies to encourage exercise and avoid
behavioral problems associated with in-
creased activity may make exercise
training most effective and most rea-
sonable given the circumstances. Care-
givers have been successfully trained to
reduce patient depression,18 agita-
tion,19,20 and delay institutionaliza-
tion.21 The attention and activity in-
herent in exercise programs can be
an opportunity to improve patient-
caregiver interactions. If positive be-
havioral strategies are used for encour-
aging exercise participation, exercise
may increase opportunities for pleas-
ant interactions between patient and
caregiver and conflicts may be re-
duced. Thus, a caregiver-supervised ex-
ercise program for patients with Alz-
heimer disease may yield significant
improvements in physical health, affect,
and behavioral distress.
This study was undertaken to deter-
mine whether a home-based exercise
program combined with caregiver train-
ing in behavioral management tech-
niques would reduce functional depen-
dence and delay institutionalization
among patients with Alzheimer dis-
ease. The Reducing Disability in Alz-
heimer Disease (RDAD) program was
compared with routine medical care in
a randomized controlled clinical trial.
It was hypothesized that patients in the
RDAD program would show signifi-
cant improvement on measures of
physical frailty and depression com-
pared with those obtained among pa-
tients in the routine care group.
METHODS
Patients
A total of 153 patients were random-
ized from an ongoing, community-
based Alzheimer disease patient regis-
try22 and through referrals from
physician practices and community ad-
vertisements. Enrollment began in June
1994 and follow-up ended in April
1999. The study was approved by in-
stitutional review boards of both the
University of Washington and Group
Health Cooperative. Written consent
was obtained from both patient and
caregiver. Additionally, caregivers (next
of kin or legal guardians) provided con-
sent on behalf of patients. All patients
received a comprehensive, multi-
disciplinary diagnostic evaluation, and
results were reviewed at consensus
meetings attended by a geriatrician,
neurologist, psychologist, epidemiolo-
gist, nurse, and research staff.
All patients met National Institute of
Neurological and Communicative Dis-
eases and Stroke/Alzheimer Disease and
Related Disorders Association criteria23
for probable or possible Alzheimer dis-
ease, were required to be community-
dwelling, ambulatory, and to have a care-
giver who was willing to participate in
training sessions. Patients ranged in age
from 55 to 93 years, were predomi-
nantly male (59%), white (89%), and had
dementia for an average of 4.3 years. Pa-
tients’ mean (SD) Mini-Mental State Ex-
amination (MMSE) score was 16.8 (7.1),
which placed them in the moderate to
severe range of cognitive impairment.
Caregivers
The caregivers were spouses or adult
relatives who lived with or spent a mini-
mum of 4 hours every day with the pa-
tient. Caregivers’ ages ranged from 24
to 91 years; 70% were female, 87% were
white, and 80% were spouses.
Procedures
Patient-caregiver dyads were ran-
domly assigned to exercise plus behav-
ior management techniques (RDAD pro-
gram) or routine medical care. The
random allocation sequence was ob-
tained from a computer program that
blocked groups of 8 patients. Dyads were
randomized after the baseline assess-
ment by research coordinators. Assess-
ments were conducted at screening,
baseline, after 3 months (posttreat-
ment) and at 6, 12, 18, and 24-month
follow-up by interviewers blind to treat-
ment assignment (FIGURE).
Trial Groups
The active treatment program (RDAD)
was adapted from 2 previously estab-
lished treatments—one to reduce be-
havioral problems in Alzheimer dis-
ease18 and one to increase exercise
among older adults.24 Patient-caregiver
dyads assigned to this program were seen
in their own homes for 12 hour-long ses-
sions on a schedule of 2 sessions per
week for the first 3 weeks, followed by
weekly sessions for 4 weeks, and then
biweekly sessions over the next 4 weeks.
Three follow-up sessions were con-
ducted over the next 3 months to an-
swer questions and consolidate treat-
ment gains. Home health professionals
experienced in dementia care con-
ducted all sessions.
The exercise component of the RDAD
program included aerobic/endurance ac-
tivities, strength training, balance, and
flexibility training. The goal was for pa-
tients to engage in a minimum of 30
min/d of moderate-intensity exercise. In
the behavioral management compo-
nent of the RDAD program, caregivers
were taught to identify and modify
patient behavioral problems that im-
paired day-to-day function and ad-
versely affected patient-caregiver inter-
actions. Caregivers were given specific
instructions about how to reduce the oc-
currence of these problems while also
teaching them skills to identify and
modify precipitants of patient distress.
Caregivers were also educated about de-
mentia, its impact on patient behavior
and function, and how to modulate their
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own responses to problems. The care-
givers were encouraged to identify pleas-
ant activities for their patients to en-
courage positive interactions and to
increase physical and social activity.
In each session, exercises were
demonstrated and practiced, care-
givers were taught how to encourage
and help patients with their exercises,
and behavioral plans were developed
and implemented. A new topic was
introduced in each of the first 10 ses-
sions; subsequent sessions focused on
solidifying gains and helping care-
givers and patients maintain exercise
and behavioral management after the
study ended. A complete RDAD treat-
ment manual is available from the
corresponding author and a descrip-
tion of the intervention has been pub-
lished previously.25
Patients in the control group re-
ceived routine medical care, includ-
ing acute medical or crisis interven-
tion provided at community health care
centers. This could include nonspe-
cific advice and support routinely pro-
vided by nurses and primary care phy-
sicians or community support services.
Specific exercise and behavioral man-
agement training was not provided to
control patients.
Trainers and Training Adherence
Treatment adherence was maintained
and monitored by weekly supervision
of each trainer by clinical geropsycholo-
gists (L.T., S.M.M.) and a physical
therapist. Treatment sessions were vid-
eotaped and reviewed by independent
raters to ensure that trainers followed
the treatment protocol.
Primary Outcome Measures
The primary patient outcomes were
physical health and function and affec-
tive status. We hypothesized that pa-
tients receiving RDAD would improve
in each area. However, because not all
patients entered the study with affec-
tive or behavioral disturbance, we be-
lieved that these areas would show im-
provement only in patients for whom
such problems were evident at base-
line. We also hypothesized that physi-
cal health and function would show the
most gain because this domain was rel-
evant across all patients.
Physical Health and Function. Two
subscales of the Medical Outcome Study
36-item Short-Form Health Survey (SF-
36; physical functioning and physical
role functioning) and 3 from the Sick-
ness Impact Profile (SIP; body care and
movement, mobility, and home man-
agement subscales) were obtained. The
SF-36 and SIP assess general health sta-
tus, are psychometrically sound, and
have been used extensively with older
adults.26,27 Higher SF-36 scores indi-
cate better health functioning; higher
SIP scores indicate worse function.
Caregivers completed these measures
based on their personal experience with
the patients.
Affective Status. Professional inter-
viewers assessed depression based on di-
rect observations of the patient and care-
giver interviews. We used the Hamilton
Depression Rating Scale28,29 and the Cor-
nell Scale for Depression in Demen-
tia,30 which are psychometrically sound
measures that have been used to assess
depression in older adults with demen-
tia.31,32 Higher scores indicate greater im-
pairment. Interviewers were trained and
periodically monitored by a clinical gero-
psychologist (S.M.M.) to ensure inter-
rater reliability.
Figure. Flow of Patients and Caregivers Through the Trial
76 Assigned to Receive Exercise Program
Plus Behavioral Management
(Reducing Disability in Alzheimer Disease)
77 Assigned to Receive Routine Medical Care
381 Patients Assessed for Eligibility
76 Included in Primary Analysis 77 Included in Primary Analysis
153 Randomized
62 Assessed at 6 mo
6 Discontinued (Patients Institutionalized)
64 Assessed at 6 mo
8 Discontinued 
5 Patients Institutionalized
1 Caregiver Died
1 Patient and Caregiver Moved From Area
1 Patient Declined to Continue
45 Assessed at 24 mo
5 Discontinued
1 Caregiver Ill
3 Patients Institutionalized
1 Caregiver Declined to Continue
44 Assessed at 24 mo
6 Discontinued
1 Caregiver Ill
4 Patients Institutionalized
1 Patient Died
49 Assessed at 18 mo
7 Discontinued
1 Not Assessed
4 Patients Institutionalized
3 Patients Died
47 Assessed at 18 mo
8 Discontinued
3 Not Assessed
6 Patients Institutionalized
2 Patients Died
57 Assessed at 12 mo
5 Discontinued
3 Patients Institutionalized
2 Patients Died
58 Assessed at 12 mo
6 Discontinued
5 Patients Institutionalized
1 Patient Declined to Continue
68 Received Intervention as Assigned and Assessed
at 3 mo (End of Intervention)
8 Discontinued
5 Patients Institutionalized
1 Patient and Caregiver Moved From Area
2 Caregivers Declined to Continue
72 Received Intervention as Assigned and Assessed
at 3 mo (End of Intervention)
5 Discontinued
2 Patients Institutionalized
1 Patient Died
2 Caregivers Declined to Continue
228 Excluded
144 Not Eligible
74 Refused Participation
10 Not Able to Contact
EFFECT OF EXERCISE ON PATIENTS WITH ALZHEIMER DISEASE
©2003 American Medical Association. All rights reserved. (Reprinted) JAMA, October 15, 2003—Vol 290, No. 15 2017
Downloaded From: https://jamanetwork.com/ by a University of California - San Diego User  on 06/20/2019
Secondary Outcome Measures
Patient performance-based and care-
giver-report assessments were ob-
tained. Patient walking speed, func-
tional reach, and standing balance were
measured. These measures of physical
health and function have been used ex-
tensively in trials of healthy older
adults.33-35 Caregiver reports included
the number of minutes spent walking
or doing another aerobic activity for ex-
ercise in the past week; the number of
restricted activity days and days spent
in bed during the past 2 weeks; and falls
and near falls during the past month.
These measures have demonstrated va-
lidity in healthy older adults36,37 and are
responsive to change.38 To our knowl-
edge, this is the first trial using these
measures with dementia patients. To as-
sess the level of patient behavioral dis-
turbance and caregiver distress, the Re-
vised Memory and Behavior Problem
Checklist was used. Good psychomet-
ric reliability and validity have been re-
ported with use of this checklist.39
Baseline Descriptive Data
and Process Measures
Baseline demographic information was
reported for patient and caregiver age,
sex, ethnic group, education, and re-
lationship. Patient age at onset and du-
ration of dementia were obtained at
screening. In addition, patient cogni-
tive status was assessed using the
MMSE.40 No change was hypoth-
esized in the MMSE as a function of
treatment; it was obtained for descrip-
tive purposes. Caregivers completed an
adverse symptom checklist at each visit.
No unexpected or serious adverse
events were attributed to the RDAD
program, and there was no difference
between active and control groups in
adverse symptoms. Exercise compli-
ance was assessed using daily exercise
logs completed by caregivers, and rat-
ings of exercise homework completed
by trainers.25 Completion of assigned
behavioral management homework (eg,
recommended readings, viewing a train-
ing videotape, or implementing a be-
havioral change plan) was also rated af-
ter each session by study trainers.
Statistical Methods
The study was designed to have 80%
power (=.05) to detect at least half SD
difference on the primary outcome mea-
sure. Between-group comparisons of
baseline covariates were conducted us-
ing Fisher exact tests, t tests, or non-
parametric Kruskal-Wallis tests. Cox
proportional hazards survival analy-
ses were used to determine which base-
line characteristics significantly pre-
dicted patient attrition. Hazard ratios
and 95% confidence intervals (CIs)
were computed.
Outcome analyses compared the
RDAD group with the routine care
group using generalized estimating
equations for linear, logistic, and Pois-
son regression.41 Mean (SD) differ-
ences, odds ratios, and relative risks
were calculated with 95% CIs.
For pretrial and posttrial analyses, the
outcome at the 3-month visit (corre-
sponding to the end of the interven-
tion) was regressed on treatment group,
controlling for the baseline value of that
factor. Pretrial and postrial analyses
were based on the intention-to-treat
(ITT) principle, using all randomized
patients. Baseline values were carried
forward for patients missing the post-
test. In secondary analyses, these analy-
ses were repeated without imputation
for missing posttests, and nonparamet-
ric Kruskal-Wallis tests were con-
ducted on the change scores. SAS sta-
tistical software was used to perform
analyses (Version 6.12; SAS Institute
Inc, Cary, NC).
Longitudinal analyses used all 5 post-
treatment visits (3, 6, 12, 18, and 24
months) and time, controlling for the
baseline value of the outcome. This is
a repeated-measures design, with up to
5 observations per person. To account
for within-patient correlation of scores
at different time points, an autoregres-
sive correlation structure was mod-
eled, which assumed that consecutive
visits were more highly correlated than
nonconsecutive visits. Time by group
interactions were assessed with the
same model structure and were re-
ported if significant. Potential con-
founders (age, sex, MMSE score at base-
line, and duration of dementia) were
evaluated by entering their baseline val-
ues as covariates and noting the change
in the estimated treatment coefficient.
Changes of more than 15% were con-
sidered to be evidence of confound-
ing. Two sets of longitudinal analyses
were conducted. The primary longitu-
dinal analyses used all available data for
each patient. In the complete fol-
low-up analyses, only patients with 24
months of follow-up were included. In
addition, a sensitivity analysis of miss-
ing data was conducted. Outcome data
were ranked by visit and missing data
were assigned the best or the worst rank
in the following combinations: (1) all
worst, (2) all best, (3) control worst and
RDAD best, and (4) control best and
RDAD worst.
RESULTS
Demographics and Baseline Scores
There were no significant differences at
baseline in any patient or caregiver
characteristics (such as age, sex, dura-
tion of dementia, and medication use)
or assessment measures (TABLE 1).
ITT Outcome Analyses
At 3 months (posttest), significant dif-
ferences were obtained between groups
for the primary measures of physical
role function and affective status. In re-
gression analyses, the mean estimated
difference for the SF-36 was 19.29 (95%
CI, 8.75-29.83; P.001), and it was
−1.03 (95% CI, −0.17 to 1.19; P=.02)
for the Cornell Depression Scale. For
both outcomes, patients in the RDAD
group improved while routine care pa-
tients declined. Using ITT, an improve-
ment of 5.9 points on the SF-36 physi-
cal role functioning subscale was
obtained for RDAD patients com-
pared with a decline of 16.6 points for
control patients; on the Cornell scale,
an improvement of 0.5 points for RDAD
patients compared with a decline of 0.5
for control patients. Significant differ-
ences were also obtained on second-
ary physical and health function mea-
sures. At baseline, 56% of those in both
the control and RDAD groups re-
ported exercising at least 60 min/wk.
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At posttest, 79% of those in the RDAD
group and 62% of those in the routine
care group reported exercising 60 min/
wk, which is an improvement of 23%
for the RDAD group vs 6% for the con-
trol group (odds ratio, 2.82; 95% CI,
1.25-6.39; P=.01). Restricted activity
days decreased by an average of 0.5 days
in the RDAD group, but increased by
0.2 days in the control group (odds ra-
tio, 3.10; 95% CI, 1.08-8.95; P.001).
The percentage of RDAD patients ex-
periencing restricted days was also
lower. No other significant differ-
ences were obtained. Nonparametric
Kruskal-Wallis tests were conducted on
the pretrial and posttrial change scores
to verify distributional assumptions. Re-
sults were similar.
Longitudinal Data for 24 Months
At 24 months of follow-up, significant
differences remained between pa-
tients in the RDAD group and the con-
trol group on the SF-36 physical role
functioning subscale (mean differ-
ence, 10.89; 95% CI, 3.62-18.16;
P= .003). Significant differences be-
tween RDAD and routine care pa-
tients emerged on the SIP Mobility
scale (relative risk, 1.27; 95% CI, 1.03-
1.56; P=.02). TABLE 2 presents the ob-
served data before imputation for miss-
ing posttests. The longitudinal analyses
were repeated with the 89 patients who
completed all 24 months of follow-up.
Significant differences were again ob-
tained between the RDAD group and
the routine care group on the SF-36
physical role functioning subscale
(mean difference, 10.59; 95% CI,
2.22-18.96; P=.01) and SIP Mobility
scale (relative risk, 1.37; 95% CI, 1.07-
1.75; P=.01).
In the sensitivity analyses, the SF-36
physical role functioning scores were
robust for most of the possible assump-
tions about the 22% of patients who
were missing data. Under most sce-
narios, the RDAD intervention im-
proved patients’ physical functioning
(mean difference, 9.18; 95% CI, 1.57-
16.78 [all worst]; mean difference, 8.81;
95% CI, −2.62 to 20.24 [all best]; mean
difference, 48.26; 95% CI, 38.67-
57.85 [RDAD group best and control
worst]; mean difference, 10.45; 95% CI,
4.06-16.85 [complete data]). Only in
the most extreme combination, in
which all the missing control patients
would have had the best scores and all
the missing RDAD patients would have
had the worst scores, would the rou-
tine care have been better than RDAD
intervention. For the SIP Mobility scale,
assigning RDAD the best ranks and con-
trol the worst retained the signifi-
cance of the findings.
Rates and Reasons for Dropouts
Of 153 patients who began the study,
140 (92%) completed posttest assess-
ment. Of the 13 who discontinued at 3
months, 8 had been assigned to the
RDAD group and 5 to the routine care
group (Fisher exact test,P=.40). Eighty-
nine (58%) completed 24-month assess-
ments. Patients who completed this last
assessment were less cognitively im-
paired (baseline MMSE score hazard ra-
tio, 1.36; 95% CI, 1.15-1.61) and had an
average MMSE score that was 5 points
lower (P.001). There were no other
significant demographic differences be-
tween those who completed this assess-
ment and those who did not.
Patient institutionalization was the
major reason patients did not com-
plete all assessments, with no signifi-
cant differences between treatment
arms (67% for the control group and
68% for the RDAD group; 21=0.04
and P=.84). However, the reasons for
Table 1. Baseline Characteristics of Alzheimer Disease Patients and Caregivers*
Characteristic
Reducing Disability
in Alzheimer Disease
(n = 76)
Routine
Medical Care
(n = 77)
Participant
Age, mean (SD), y 78 (6) 78 (8)
Sex
Male 48 (63) 42 (55)
Female 28 (37) 35 (45)
Race/ethnicity
Asian/Pacific Islander 1 (1) 3 (4)
Black 8 (11) 5 (6)
White 67 (88) 69 (90)
Married 62 (82) 63 (82)
Years of education, mean (SD) 13 (3) 13 (3)
Duration of dementia, mean (SD), y 4 (3) 5 (3)
Mini-Mental State Examination score, mean (SD) 17.6 (6.8) 15.9 (7.4)
Medication use
All psychotropics 16 (21) 18 (23)
Cognitive enhancers 5 (7) 7 (9)
Caregiver
Age, mean (SD), y 70 (13) 70 (13)
Sex
Male 20 (26) 26 (34)
Female 56 (74) 51 (66)
Race/ethnicity
Native American or Alaska Native 1 (1) 0
Asian/Pacific Islander 3 (4) 3 (4)
Black 7 (9) 5 (6)
Hispanic 1 (1) 0
White 64 (84) 69 (90)
Years of education, mean (SD) 14 (3) 13 (3)
Relationship with participant
Spouse 60 (79) 62 (81)
Adult child 4 (5) 5 (6)
Other 12 (16) 10 (13)
*Values are expressed as number (percentage) unless otherwise indicated. All group comparisons P.05.
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patient institutionalization did differ
(TABLE 3). Eleven control patients
(50%) were institutionalized because of
patient behavioral problems com-
pared with 4 RDAD patients (19%).
One control patient (5%) was institu-
tionalized because of caregiver health
or caregiver availability compared with
8 RDAD patients (38%).
Additional Analyses
We further investigated patients with
preexisting mood disturbance to de-
termine whether those with problems
were more or less likely to benefit from
intervention. Patients with a score of 6
or greater on the Cornell scale were se-
lected because this score was above our
sample mean score at baseline. For these
patients, Hamilton Depression Rating
scale scores were examined. In ITT
analysis, RDAD patients improved at
posttest (mean [SD], 2.0 [4.9]) while
control patients worsened (mean [SD],
0.6 [5.1]). The mean adjusted differ-
ence was 2.21 (95% CI, 0.22-4.20;
P=.04). Over 24 months of follow-up,
this difference of 2.14 (95% CI, 0.14-
4.17) remained statistically signifi-
cant (P=.04).
Baseline cognitive status (MMSE
score), patient or caregiver sex, and du-
ration of dementia did not affect re-
sults. Analyses of treatment compli-
ance data completed by study trainers
showed that 91% of RDAD patients
attempted their exercise homework
(79% completed 75% of assigned
homework). Only 9% of RDAD pa-
tients did not complete any home-
work.
COMMENT
This study demonstrated that an inte-
grated treatment program designed to
train dementia patients and their care-
givers in exercise and behavioral man-
agement techniques was successfully
implemented in a community setting.
Caregivers were able to learn how to en-
courage and supervise exercise partici-
pation, and patients participating in this
program achieved increased levels of
physical activity, decreased rates of de-
Table 2. Significant Outcomes
No. of
Participants
Mean (SD) Score
No. (%) of
Participants Who
Exercised 60 min/wkSF-36
SIP
Mobility
Cornell
Depression in
Dementia Scale
Restricted
Activity, d
Baseline
Routine medical care 77 67.9 (35.1) 14.2 (13.8) 5.8 (4.5) 0.4 (2.2) 43 (56)
RDAD 76 62.2 (36.6) 16.3 (19.2) 5.7 (3.9) 0.6 (2.2) 43 (56)
Posttest (3 mo)
Routine medical care 72 50.7 (39.1) 15.2 (17.1) 6.2 (3.8) 0.6 (2.5) 45 (62)
RDAD 68 72.1 (33.0) 16.0 (17.1) 5.2 (3.6) 0.1 (0.4) 56 (82)
6 mo
Routine medical care 64 60.9 (35.0) 16.7 (16.2) 6.5 (4.4) 0.6 (2.3) 44 (69)
RDAD 62 64.9 (36.1) 17.4 (20.7) 6.4 (3.8) 0.3 (1.8) 40 (64)
12 mo
Routine medical care 58 62.1 (37.8) 15.9 (14.7) 7.1 (4.5) 0.7 (2.3) 34 (59)
RDAD 57 68.9 (32.8) 16.0 (19.7) 7.0 (4.5) 0.9 (3.3) 36 (64)
18 mo
Routine medical care 47 61.2 (34.5) 20.6 (18.7) 7.5 (5.7) 1.1 (3.7) 24 (52)
RDAD 49 71.4 (37.8) 14.6 (17.1) 6.3 (4.3) 0.3 (2.0) 34 (69)
24 mo
Routine medical care 44 57.4 (40.2) 21.0 (18.8) 7.4 (5.0) 0 (0.3) 20 (45)
RDAD 45 60.0 (41.1) 18.9 (17.1) 6.4 (4.5) 0.9 (3.2) 23 (51)
Pre (baseline) and post (3 mo)
intention-to-treat P Value
.001 .17 .02 .001 .01
Longitudinal P Value
(all posttreatment visits)*
.01 .02 .10 .45 .13
Abbreviations: RDAD, Reducing Disability in Alzheimer Disease; SF-36, 36-item Short-Form Health Survey; SIP, Sickness Impact Profile.
*Longitudinal analysis used all 5 posttreatment visits.
Table 3. Reasons and Amount of Withdrawals*
Reducing Disability
in Alzheimer Disease
(n = 76)
Routine Medical Care
(n = 77)
Withdrawals 31 (41) 33 (43)
Patient institutionalized 21 (68) 22 (67)
Behavioral problems of patient 4 (19) 11 (50)
Impairment or illness of patient 4 (19) 4 (18)
Increased ADL impairment of patient 5 (24) 6 (27)
Ill health or death of caregiver 8 (38) 1 (5)
Unwilling or unable to continue
Caregiver 5 (16) 5 (15)
Patient 5 (16) 6 (18)
Abbreviation: ADL, activities of daily living.
*Values are expressed as number (percentage).
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pression, and improved physical health
and function. Patients in the RDAD
group fared significantly better than
those in the control group. Scores on
the SF-36 Physical Role Functioning
subscale, Cornell Depression scale, and
the number of restricted activity days
all significantly improved. Posttest
physical function improvements were
maintained at 24-month follow-up and,
for those patients entering with higher
levels of initial depression, improve-
ments in depression were maintained
after 24 months.
The reasons for patient institution-
alization throughout the 24-month fol-
low-up period differed between pa-
tients in the RDAD group and in the
routine care group. Eleven routine care
patients (50%) who discontinued the
study due to institutionalization did so
because he/she experienced an in-
crease of behavioral problems com-
pared with only 4 (19%) of 21 in the
RDAD group (Table 3). These num-
bers are small but suggest that the
RDAD program may have influenced
patients and caregivers to a significant
enough degree to delay institutional-
ization caused by an inability to man-
age patient behavioral disturbances.
Adherence to program recommenda-
tions was quite high demonstrating that
community-dwelling caregivers can be
successfully trained to supervise a home
exercise program for persons with de-
mentia. Although other studies have
found that exercise professionals in
structured institutional settings can
implement exercise programs,10,42-44 this
is the first to show that a simplified ex-
ercise program can be taught to care-
givers of dementia patients residing in
the community. Furthermore, this study
involved a heterogeneous array of pa-
tients and caregivers, lending support to
the generalizability of these findings.
We included both caregivers and
patients in this intervention. We did not,
however,assess thedegree towhichcare-
givers felt satisfied with what they were
learning, nor did we assess the poten-
tial outcomes of treatment on care-
givers. It became clear as we conducted
the study that caregivers were benefit-
ing from participation, but the nature of
that benefit and its potential impact on
their caregiving was not determined. We
also did not investigate the relative effi-
cacy of exercise or behavioral manage-
ment in producing the results reported
herein. We were interested in the com-
bined effect of both treatment compo-
nents because we were interested in
improving both physical and affective
health. Now that the combination has
been shown efficacious in producing
change, we would be interested in
exploring the relative effectiveness of
each component alone as well as the
impact of treatment on caregivers them-
selves. While we hypothesize that the
combination is superior and that care-
givers benefit from training, these are
empirical questions worthy of inquiry.
Future research is needed to deter-
mine whether the effects obtained herein
can be replicated or improved. Given
that our depressed patients improved,
a more targeted approach may show
stronger results. That would be consis-
tent with our own earlier work in which
we found that a targeted behavioral ap-
proach was successful in reducing the
levels of depression in dementia pa-
tients and their caregivers.18 Because ex-
ercise is also associated with reduced de-
pression in adults without dementia,
targeting patients with coexisting de-
pression and dementia might enhance
treatment effects. Given these results and
the consistently strong association be-
tween physical exercise and health in
older adults without dementia,13-15 the
potential health benefits of a simple ex-
ercise program for older adults with de-
mentia should not be overlooked.
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